Auster Martin

Auster Martin serves as the Chief Financial Officer of Ventyx Biosciences, Inc., a company in the healthcare sector. His recent disclosures, tracked through SEC Form 4 filings, highlight a series of sale activities between December 19, 2023, and April 3, 2024. Notably, the largest disclosed transaction involved a grant/exercise valued at approximately $387.9K, reflecting a range of sale amounts from $7.6K to $387.9K across four disclosures.